Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

NCT06396299 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT06396299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06396299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
Lead sponsor
Mahidol University
Phase
Observational
Overall status
Recruiting
Start date
June 2, 2024
Completion date
June 1, 2030
Enrollment
4,000 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation